✦ LIBER ✦

A novel transthyretin mutation V32A in a Chinese man with late-onset amyloid polyneuropathy

✍ Scribed by Emmanuel C. Pica; Zacharias Ad Pramono; Kamal K. Verma; Lai Poh San; Yee Woon Chee

Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 114 KB
Volume: 32
Category: Article
ISSN: 0148-639X
DOI: 10.1002/mus.20331

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

New transthyretin mutation V28M in a Por

New transthyretin mutation V28M in a Portuguese kindred with amyloid polyneuropathy

✍ Mamede de Carvalho; Paulo Moreira; Teresinha Evangelista; José Luis Ducla-Soares 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 372 KB 👁 1 views

Novel amyloid precursor protein gene mut

Novel amyloid precursor protein gene mutation (codon 665Asp) in a patient with late-onset Alzheimer's disease

✍ M. L. Peacock; D. L. Murman; A. A. F. Sima; J. T. Warren Jr.; A. D. Roses; Dr. J 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 683 KB

Large Family With Maturity-Onset Diabete

Large Family With Maturity-Onset Diabetes of the Young and a Novel V121I Mutation in HNF4A

✍ Carole T. Monney; Valérie Kaltenrieder; Pascal Cousin; Christophe Bonny; Daniel 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB 👁 1 views

Maturity-onset diabetes of the young (MODY) is a subtype of early-onset diabetes mellitus which is characterized by autosomal dominant inheritance. Several genes are known to induce MODY : HNF4A/MODY1, GCK/MODY2, TCF1/MODY3, IPF1/MODY4, TCF2/MODY5 and NEUROD1/MODY6. We studied a Swiss family with 13

A novel mutation of the GAA gene in a Fi

A novel mutation of the GAA gene in a Finnish late-onset pompe disease patient: Clinical phenotype and follow-up with enzyme replacement therapy

✍ Mari P. Korpela; Anders Paetau; Mervi I. Löfberg; Marjut H. Timonen; Antti E. La 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB

## Abstract Pompe disease is a rare, progressive disease leading to skeletal muscle weakness due to deficiency of the acid α‐glucosidase (GAA) enzyme. Herein we report the first diagnosed Finnish patient with a phenotype compatible with the late‐onset form of Pompe disease. Molecular genetic analys

Late-onset Charcot-Marie-Tooth type 2 di

Late-onset Charcot-Marie-Tooth type 2 disease with hearing impairment associated with a novel Pro105Thr mutation in the MPZ gene

✍ Dagmara Kabzińska; Teresa Korwin-Piotrowska; Hanna Drechsler; Hanna Drac; Irena 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 189 KB 👁 1 views

Screening of SLC25A13 mutations in early

Screening of SLC25A13 mutations in early and late onset patients with citrin deficiency and in the Japanese population: Identification of two novel mutations and establishment of multiple DNA diagnosis methods for nine mutations

✍ Naoki Yamaguchi; Keiko Kobayashi; Tomotsugu Yasuda; Ikumi Nishi; Mikio Iijima; M 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 539 KB

We have recently identified SLC25A13 on chromosome 7q21.3 as the gene responsible for adultonset type II citrullinemia (CTLN2) and found seven mutations in the SLC25A13 gene of CTLN2 patients. Most recently, the SLC25A13 mutations have been detected in neonatal/infantile patients with a type of neon